FP

Flagship Pioneering Inc.

13F
Flagship Pioneering Inc.
Last update 2024-08-14 6 Stocks (0 new)
Value $843.00 Mil Turnover 0 %
Countries:
Top Holdings: MRNA(65.22%)SANA(16.19%)FHTX(8.64%)OMGA(7.17%)MCRB(1.98%)
Portfolio Report
Summary Stock Picks Current Portfolio
Flagship Pioneering Inc. Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
MRNA 		Moderna Inc
4,632,149
550067.700
-52.08%
65.220
-35.18%
1.210
-38.34%
-49.44%
19348.640
Biotechnology
SANA 		Sana Biotechnology Inc
25,001,856
136510.130
0%
16.190
0%
11.240
-34.32%
-24.02%
689.644
Biotechnology
FHTX 		Foghorn Therapeutics Inc
12,674,120
72876.190
0%
8.640
0%
22.910
+80.75%
+41.24%
506.453
Biotechnology
OMGA 		Omega Therapeutics Inc
29,225,579
60496.950
0%
7.170
0%
52.990
-26.80%
-62.79%
61.774
Biotechnology
MCRB 		Seres Therapeutics Inc
23,117,045
16732.120
0%
1.980
0%
15.240
-18.73%
-48.91%
121.727
Biotechnology
SYRS 		Syros Pharmaceuticals Inc
1,293,849
6676.260
0%
0.790
0%
4.830
-48.90%
-67.14%
68.691
Biotechnology
DNLI 		Denali Therapeutics Inc
0
0.000
Sold Out
0.000
-1.84%
0.000
+36.53%
+37.93%
4260.080
Biotechnology

Flagship Pioneering Inc.'s Historical Top Holdings Breakdowns

Flagship Pioneering Inc.'s Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
MRNA 		Moderna Inc2024-06-30Reduce
-35.18%
●
101.21 ($126.55) 166.61
$50.28
-60.27%
Reduce -52.08%
4,632,149
-5,033,889
DNLI 		Denali Therapeutics Inc2024-06-30Sold Out
-1.84%
●
14.96 ($19.2) 23.22
$29.60
54.17%
Sold Out
0
-1,364,516
DNLI 		Denali Therapeutics Inc2024-03-31Reduce
-1.55%
●
15.83 ($18.79) 23.35
$29.60
57.53%
Reduce -41.18%
1,364,516
-955,452
EVLO 		Evelo Biosciences Inc2023-12-31Sold Out
-2.26%
●
0.04 ($0.89) 3.75
$0
-99.97%
Sold Out
0
-7,932,624
AXLA Axcella Health Inc2023-12-31Sold Out
-0.89%
●
0.4 ($4.71) 10.65
$0.40
-91.49%
Sold Out
0
-1,170,059
DNLI 		Denali Therapeutics Inc2023-12-31Reduce
-0.45%
●
16.2 ($19.81) 23.18
$29.60
49.42%
Reduce -11.45%
2,319,968
-300,000
SYRS 		Syros Pharmaceuticals Inc2023-12-31Add
+0.18%
●
2.13 ($3.43) 7.79
$2.56
-25.36%
Add 30.19%
1,293,848
300,000
MRNA 		Moderna Inc2023-09-30Reduce
-17.46%
●
96.41 ($111.55) 126.61
$50.28
-54.93%
Reduce -24.99%
9,666,038
-3,220,705
SANA 		Sana Biotechnology Inc2023-09-30Reduce
-2.20%
●
3.77 ($5.37) 6.23
$3.10
-42.27%
Reduce -24.9%
25,001,856
-8,288,162
EVLO 		Evelo Biosciences Inc2023-09-30Add
+1.54%
●
2.31 ($6.82) 13.31
$0
-100.00%
Add 214.62%
7,932,624
5,411,255

Flagship Pioneering Inc. Total Holding History ($B)

To

Flagship Pioneering Inc.'s Asset Allocation

To

Flagship Pioneering Inc. Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Flagship Pioneering Inc.'s Hypothetical Growth since 2024-06-30

Flagship Pioneering Inc.'s Yearly Returns

Year Portfolio % % Excess Gain %

Flagship Pioneering Inc.'s Holdings Heat Map

Size field:

Flagship Pioneering Inc.'s Holdings Bubble Chart

Flagship Pioneering Inc. News

  • 1

Discussions on Flagship Pioneering Inc.

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.